NasdaqGS - Nasdaq Real Time Price USD

Inogen, Inc. (INGN)

Compare
11.26 -0.07 (-0.62%)
At close: September 10 at 4:00 PM EDT
Loading Chart for INGN
DELL
  • Previous Close 11.33
  • Open 11.28
  • Bid 11.21 x 100
  • Ask 11.28 x 100
  • Day's Range 10.96 - 11.33
  • 52 Week Range 4.13 - 13.33
  • Volume 140,177
  • Avg. Volume 197,148
  • Market Cap (intraday) 267.076M
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -3.97
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.00

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

www.inogen.com

834

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INGN

View More

Performance Overview: INGN

Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INGN
105.10%
S&P 500
15.21%

1-Year Return

INGN
87.67%
S&P 500
23.29%

3-Year Return

INGN
77.63%
S&P 500
22.31%

5-Year Return

INGN
73.70%
S&P 500
84.51%

Compare To: INGN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INGN

View More

Valuation Measures

Annual
As of 9/10/2024
  • Market Cap

    267.08M

  • Enterprise Value

    170.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.81

  • Price/Book (mrq)

    1.42

  • Enterprise Value/Revenue

    0.52

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.30%

  • Return on Assets (ttm)

    -10.00%

  • Return on Equity (ttm)

    -39.99%

  • Revenue (ttm)

    326.65M

  • Net Income Avi to Common (ttm)

    -92.44M

  • Diluted EPS (ttm)

    -3.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    117.69M

  • Total Debt/Equity (mrq)

    11.43%

  • Levered Free Cash Flow (ttm)

    5.53M

Research Analysis: INGN

View More

Company Insights: INGN

Research Reports: INGN

View More

People Also Watch